Altimmune, Inc. Share Price
NASDAQ: ALT | Micro CapAltimmune, Inc. Stock Performance
Altimmune, Inc. Share Price Today
As of 19 September 2026, Altimmune, Inc.'s share price is $3.26. The stock opened at $3.22, compared to its previous close of $3.25. During today's trading session, Altimmune, Inc.'s share price traded between $3.18 and $3.25, with an average price of $3.22. Over the past 52 weeks, the stock has recorded a high of $6.42 and a low of $2.56. In terms of performance, Altimmune, Inc.'s share price has risen by 6.19% over the last six months and is down 13.53% on a year-on-year basis.
Altimmune, Inc. Share Price Chart
Altimmune, Inc. Quarterly Profit & Loss
All figures in USD
Altimmune, Inc. Annual Profit & Loss
All figures in USD
About Altimmune, Inc.
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
Altimmune, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $3.08 | $3.25 | +0.15% |
Aug 2026 | $2.90 | $3.25 | +13.86% |
Jul 2026 | $3.06 | $2.85 | -5.79% |
Jun 2026 | $3.03 | $3.02 | -0.82% |
May 2026 | $2.57 | $3.05 | +18.22% |
Apr 2026 | $3.15 | $2.58 | -15.96% |
Mar 2026 | $4.22 | $3.07 | -28.77% |
Feb 2026 | $5.55 | $4.31 | -23.17% |
Jan 2026 | $3.62 | $5.61 | +55.62% |
Dec 2025 | $5.08 | $3.60 | -31.46% |
Nov 2025 | $4.02 | $5.26 | +29.88% |
Oct 2025 | $3.83 | $4.05 | +7.43% |